Group One Trading’s Lexicon Pharmaceuticals LXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $289K | Sell |
185,006
-39,302
| -18% | -$57.1K | ﹤0.01% | 3829 |
|
|
2025
Q4 | $258K | Buy |
224,308
+8,064
| +4% | +$11.1K | ﹤0.01% | 4139 |
|
|
2025
Q3 | $292K | Sell |
216,244
-130,508
| -38% | -$148K | ﹤0.01% | 4251 |
|
|
2025
Q2 | $328K | Sell |
346,752
-19,054
| -5% | -$12.3K | ﹤0.01% | 3835 |
|
|
2025
Q1 | $169K | Buy |
365,806
+51,402
| +16% | +$32.4K | ﹤0.01% | 4161 |
|
|
2024
Q4 | $232K | Buy |
+314,404
| New | +$379K | ﹤0.01% | 3817 |
|
|
2024
Q1 | – | Sell |
-16,054
| Closed | -$34.5K | – | 7578 |
|
|
2023
Q4 | $24.6K | Buy |
+16,054
| New | +$19.1K | ﹤0.01% | 5589 |
|
|
2023
Q3 | – | Sell |
-93,363
| Closed | -$164K | – | 8011 |
|
|
2023
Q2 | $214K | Buy |
93,363
+59,850
| +179% | +$159K | ﹤0.01% | 3854 |
|
|
2023
Q1 | $81.4K | Buy |
33,513
+9,289
| +38% | +$21.3K | ﹤0.01% | 4476 |
|
|
2022
Q4 | $46.3K | Sell |
24,224
-105,048
| -81% | -$224K | ﹤0.01% | 5053 |
|
|
2022
Q3 | $310K | Buy |
129,272
+34,672
| +37% | +$96K | ﹤0.01% | 3700 |
|
|
2022
Q2 | $176K | Buy |
94,600
+14,637
| +18% | +$27.9K | ﹤0.01% | 4417 |
|
|
2022
Q1 | $167K | Sell |
79,963
-54,715
| -41% | -$152K | ﹤0.01% | 4990 |
|
|
2021
Q4 | $531K | Buy |
134,678
+118,305
| +723% | +$575K | ﹤0.01% | 4075 |
|
|
2021
Q3 | $79K | Sell |
16,373
-20,210
| -55% | -$82.9K | ﹤0.01% | 6147 |
|
|
2021
Q2 | $168K | Buy |
+36,583
| New | +$176K | ﹤0.01% | 5420 |
|
|
2021
Q1 | – | Sell |
-37,089
| Closed | -$257K | – | 7824 |
|
|
2020
Q4 | $127K | Buy |
37,089
+35,099
| +1,764% | +$67K | ﹤0.01% | 4391 |
|
|
2020
Q3 | $3K | Buy |
+1,990
| New | +$3.54K | ﹤0.01% | 5756 |
|
|
2020
Q2 | – | Sell |
-9,329
| Closed | -$18.3K | – | 6004 |
|
|
2020
Q1 | $18K | Buy |
+9,329
| New | +$27.8K | ﹤0.01% | 4281 |
|
|
2019
Q1 | – | Sell |
-2,785
| Closed | -$16.9K | – | 5113 |
|
|
2018
Q4 | $18K | Buy |
+2,785
| New | +$22.6K | ﹤0.01% | 4062 |
|
|
2017
Q4 | – | Sell |
-70,092
| Closed | -$861K | – | 5048 |
|
|
2017
Q3 | $861K | Buy |
+70,092
| New | +$1.04M | 0.01% | 1667 |
|
|
2017
Q2 | – | Sell |
-3,429
| Closed | -$53.1K | – | 4921 |
|
|
2017
Q1 | $49K | Sell |
3,429
-15,134
| -82% | -$225K | ﹤0.01% | 3418 |
|
|
2016
Q4 | $257K | Buy |
18,563
+3,693
| +25% | +$59.3K | ﹤0.01% | 2251 |
|
|
2016
Q3 | $269K | Sell |
14,870
-900
| -6% | -$14.5K | ﹤0.01% | 2270 |
|
|
2016
Q2 | $226K | Buy |
15,770
+13,529
| +604% | +$183K | ﹤0.01% | 2316 |
|
|
2016
Q1 | $27K | Buy |
2,241
+1,813
| +424% | +$19K | ﹤0.01% | 3595 |
|
|
2015
Q4 | $6K | Sell |
428
-34,303
| -99% | -$422K | ﹤0.01% | 4331 |
|
|
2015
Q3 | $373K | Buy |
+34,731
| New | +$379K | 0.01% | 2014 |
|
Other funds holding LXRX
AG
SL
SC
VCM
Group One Trading's LXRX Position: Q1 2026 in Review
Group One Trading reduced its Lexicon Pharmaceuticals (LXRX) stake by 18% in Q1 2026, selling an estimated $57.1K and leaving 185,006 shares worth $289K. The position accounts for ﹤0.01% of the portfolio, ranked #3829.
Group One Trading first reported a position in LXRX in Q3 2015 and has held it in 28 quarters since. The position peaked at $861K in Q3 2017. 136 funds tracked by Wall St. Rank hold LXRX as of Q1 2026.
- Group One Trading held 185,006 shares of Lexicon Pharmaceuticals worth $289K as of Q1 2026.
- Group One Trading sold 39,302 Lexicon Pharmaceuticals shares in Q1 2026, an estimated $57.1K.
- Lexicon Pharmaceuticals made up ﹤0.01% of Group One Trading's portfolio in Q1 2026, its #3829 holding.
- Group One Trading first reported a position in Lexicon Pharmaceuticals in Q3 2015 and has held it in 28 quarters since.
- Group One Trading's Lexicon Pharmaceuticals position peaked at $861K in Q3 2017.
- 136 funds tracked by Wall St. Rank held Lexicon Pharmaceuticals as of Q1 2026.
Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.